From research to market, pharmaceutical development crosses a dozen disciplines and takes years. Most companies operate in one or two stages. Polpharma Group is integrated across all of them. The same chain that delivers our own medicines to four hundred million packs a year is open to partners, at whichever stage they need us.

Our work reaches further than a pill in a box. We make sure our medicines are available where they are needed, made by people who are paid well to make them, in factories that the next generation can still run. A healthy life and a healthy world are one and the same project.

The Group has invested where global capacity is scarce: oligonucleotide synthesis, cryogenic chemistry, high-potency containment, and dosage forms such as co-integrated dry-powder inhalers, long-acting injectables and preservative-free multidose ophthalmics. All of it runs within the Group's own plants and R&D centres, under EU GMP.